Bartlett & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bartlett & Co’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$44K	Hold	574	–	–	﹤0.01%	732
2023 Q3	$42K	Hold	574	–	–	﹤0.01%	692
2023 Q2	$43K	Hold	574	–	–	﹤0.01%	697
2023 Q1	$44K	Hold	574	–	–	﹤0.01%	588
2022 Q4	$45K	Hold	574	–	–	﹤0.01%	595
2022 Q3	$41K	Hold	574	–	–	﹤0.01%	594
2022 Q2	$43K	Hold	574	–	–	﹤0.01%	595
2022 Q1	$46K	Buy	+574	New	+$44.5K	﹤0.01%	595
2021 Q4	–	Sell	-624	Closed	-$48K	–	748
2021 Q3	$48K	Buy	624 +50	+9%	+$4.03K	﹤0.01%	515
2021 Q2	$46K	Hold	574	–	–	﹤0.01%	523
2021 Q1	$45K	Hold	574	–	–	﹤0.01%	556
2020 Q4	$41K	Hold	574	–	–	﹤0.01%	559
2020 Q3	$37K	Hold	574	–	–	﹤0.01%	533
2020 Q2	$37K	Hold	574	–	–	﹤0.01%	538
2020 Q1	$32K	Buy	+574	New	+$35K	﹤0.01%	529
2019 Q3	$33K	Hold	574	–	–	﹤0.01%	592
2019 Q2	$35K	Hold	574	–	–	﹤0.01%	481
2019 Q1	$37K	Hold	574	–	–	﹤0.01%	461
2018 Q4	$36K	Hold	574	–	–	﹤0.01%	456
2018 Q3	$42K	Hold	574	–	–	﹤0.01%	457
2018 Q2	$39K	Hold	574	–	–	﹤0.01%	450
2018 Q1	$36K	Hold	574	–	–	﹤0.01%	460
2017 Q4	$37K	Hold	574	–	–	﹤0.01%	459
2017 Q3	$38K	Hold	574	–	–	﹤0.01%	455
2017 Q2	$36K	Hold	574	–	–	﹤0.01%	462
2017 Q1	$34K	Hold	574	–	–	﹤0.01%	470
2016 Q4	$32K	Hold	574	–	–	﹤0.01%	482
2016 Q3	$35K	Hold	574	–	–	﹤0.01%	472
2016 Q2	$36K	Hold	574	–	–	﹤0.01%	474
2016 Q1	$34K	Hold	574	–	–	﹤0.01%	467
2015 Q4	$40K	Hold	574	–	–	﹤0.01%	449
2015 Q3	$38K	Hold	574	–	–	﹤0.01%	455
2015 Q2	$45K	Hold	574	–	–	﹤0.01%	445
2015 Q1	$44K	Hold	574	–	–	﹤0.01%	451
2014 Q4	$38K	Hold	574	–	–	﹤0.01%	469
2014 Q3	$37K	Hold	574	–	–	﹤0.01%	471
2014 Q2	$35K	Hold	574	–	–	﹤0.01%	489
2014 Q1	$33K	Hold	574	–	–	﹤0.01%	476
2013 Q4	$31K	Hold	574	–	–	﹤0.01%	464
2013 Q3	$26K	Buy	+574	New	+$26.2K	﹤0.01%	489

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bartlett & Co's PJP Position: Q4 2023 in Review

Bartlett & Co held its Invesco Pharmaceuticals ETF (PJP) position steady in Q4 2023 at 574 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Bartlett & Co first reported a position in PJP in Q3 2013 and has held it in 40 quarters since. The position peaked at $48K in Q3 2021. 86 funds tracked by Wall St. Rank hold PJP as of Q4 2023.

Bartlett & Co held 574 shares of Invesco Pharmaceuticals ETF worth $44K as of Q4 2023.
Bartlett & Co left its Invesco Pharmaceuticals ETF share count unchanged in Q4 2023.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #732 holding.
Bartlett & Co first reported a position in Invesco Pharmaceuticals ETF in Q3 2013 and has held it in 40 quarters since.
Bartlett & Co's Invesco Pharmaceuticals ETF position peaked at $48K in Q3 2021.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.